Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project

Cancers (Basel) , May 2026

Abruzzese E et al. Cancers(Basel), May 2026 – open access publication

Link to full abstract